Low-dose interleukin-2 immunotherapy does not improve outcome of patients age 60 years and older with acute myeloid leukemia in first complete remission: Cancer and Leukemia Group B Study 9720
- Citation:
- J Clin Oncol vol 26 (30) 4934-4939
- Meeting Instance:
- ASCO 2008
- Year:
- 2008
- Type:
- Abstract
- Sub type:
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 86
- Pharmas:
- Grants:
- CA31946, CA33601, )CA31983, CA02599, CA77658, CA35279, CA03927, CA47577, CA32291, CA41287
- Corr. Author:
- Baer
- Authors:
- Maria R. Baer Stephen L. George Michael A. Caligiuri Ben L. Sanford Sandra M. Bothun Krzysztof Mrózek Jonathan E. Kolitz Bayard L. Powell Joseph R. Moore Richard M. Stone John Anastasi Clara D. Bloomfield Richard A. Larson
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-10201, CALGB-10502, CALGB-10503, CALGB-10603, CALGB-19808, CALGB-8525, CALGB-8923, CALGB-9022, CALGB-9222, CALGB-9420, CALGB-9621, CALGB-9720
- Phases:
- 1, 1/2, 2, 3
- Keywords: